Allard van Renterghem

In April 2022 I joined the lab of Emile Voest as a clinical-PhD student after finishing my medical studies.

My researchwork at the NKI will be aimed at further improving and personalizing immunotherapy, by trying to unravel tumor-immune dynamics on a patient-specific basis. To this end, we will study the interaction between myeloid cells and tumors by using our patient-derived organoid system.